Our Services
Medical Information
Helpful Resources
Published on: 5/21/2026
Doctors diagnose acute infections using serologic assays that measure two key antibodies: IgM, which peaks within days of symptom onset and signals acute infection, and IgG, which develops later and indicates past exposure. Testing methods include single-sample titers, paired samples, or PCR for confirmation. Clinical context, symptom timing, and exposure history are equally critical in reaching an accurate diagnosis.
Because antibody results depend heavily on when symptoms began and what you've been exposed to, understanding your own symptom timeline is the essential first step. Take a free, instant, online symptom check to clarify what may be going on and confidently navigate your next steps with your doctor.
Reviewed for medical accuracy: 07/09/2026
When it comes to diagnosing hantavirus, understanding whether you've had a past exposure or are experiencing an acute (recent) infection is crucial. Doctors rely on a combination of clinical presentation, patient history and specialized laboratory tests—especially serologic assays that measure Hantavirus testing IgG and IgM titers. Here's how the process works in clear, common language.
IgM antibodies
• First line of defense, appear early in infection (usually within 5–10 days of symptoms).
• Short-lived, often detectable for weeks to a few months.
• A high IgM titer typically signals a recent or acute infection.
IgG antibodies
• Develop later (around 2–3 weeks after symptom onset).
• Remain detectable for months to years, indicating past exposure or recovery phase.
• A strong IgG response alone usually means prior infection or immunity.
Hantavirus testing IgG IgM titers help your doctor pinpoint where you are on this timeline.
| Time Since Symptom Onset | What You'll See in Blood Tests |
|---|---|
| 0–7 days | IgM may be just rising; IgG often undetectable |
| 7–14 days | IgM peaks; IgG starts to appear |
| 2–4 weeks | IgM remains; IgG strengthens |
| > 1 month | IgM declines; IgG persists |
Collecting specimens at the right time ensures accurate differentiation between acute infection and past exposure.
While serology (IgG/IgM titers) is most common, molecular tests can add clarity:
PCR (Polymerase Chain Reaction)
• Detects viral RNA directly in blood or tissue.
• Most sensitive early on, before antibody levels rise.
• A positive PCR plus negative IgG/IgM strongly indicates active infection.
Antigen Detection
• Rarely used in routine clinical care for hantavirus.
• May appear alongside PCR tests in research or specialized centers.
Combining serology with PCR gives a fuller picture, especially if timing of symptom onset is uncertain.
Laboratory results are one piece of the puzzle. Your doctor evaluates:
Together, this information confirms whether serologic patterns truly reflect an acute hantavirus infection or a past exposure.
High IgM, Low/Negative IgG
– Strongly suggests acute infection.
– May warrant hospitalization and supportive care (e.g., oxygen, fluid management).
High IgG, Negative IgM
– Consistent with prior infection or late-stage recovery.
– Often no specific antiviral treatment is needed; supportive care as needed.
Both IgM and IgG Elevated
– Likely in the subacute or early convalescent phase.
– Correlate with clinical timeline to decide on ongoing management.
Negative IgM & IgG, Positive PCR
– Very early infection—antibodies haven't formed yet.
– Requires close monitoring and possibly repeat serology.
It's natural to feel concerned about hantavirus testing IgG IgM titers. Remember:
If you're unsure whether your symptoms warrant immediate attention or just need clarity on what you're experiencing, try Ubie's Free AI Symptom Checker—it takes just a few minutes to get personalized insights based on your specific situation.
Always discuss any test results, worrisome symptoms or exposures with a qualified provider. Seek immediate attention if you experience:
No online tool replaces an in-person evaluation when serious or life-threatening issues arise.
Speak to your doctor about any concerns or test results—you deserve answers and the best possible care.
(References)
* Kastenbauer SA, Herold RWKG. Interpretation of serological results for infectious diseases: pitfalls and how to avoid them. JMM Case Rep. 2017 Nov 30;4(1):e005080. doi: 10.1099/jmmcr.0.005080. PMID: 29201407; PMCID: PMC5709974.
* Chen EEE, Lee THCT, Wu CWSM. Advances in Serologic Diagnosis of Infectious Diseases: A Review. J Clin Microbiol. 2019 May 23;57(5):e01869-18. doi: 10.1128/JCM.01869-18. PMID: 30867204; PMCID: PMC6530666.
* Li ZL, Li AKBC, Zhang CLL, Zhu YZC, Wu GWZ. Diagnostic Approaches to Active and Past Infection With SARS-CoV-2. Front Immunol. 2020 Dec 22;11:617833. doi: 10.3389/fimmu.2020.617833. PMID: 33414840; PMCID: PMC7785340.
* Dukers-Mueller C, Mølbak K, Ethelberg S, Krogfelt KA. Serological Markers for Acute and Past Campylobacter Infection in a Large, Population-Based Cohort Study. Clin Infect Dis. 2015 Oct 1;61 Suppl 8:S719-24. doi: 10.1093/cid/civ580. PMID: 26527783.
* Singh S, Mishra R, Tandon R. Molecular versus serologic detection of pathogens in clinical diagnostics: advantages and limitations. J Immunol Methods. 2022 Jan;500:113170. doi: 10.1016/j.jim.2021.113170. Epub 2021 Dec 2. PMID: 34863772.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.